On the other hand, substantially decreased AFP and DCP overall reflected the remarkable efficacy of the quadruple conversion therapy (Figure 1B), which suggests that serial AFP and DCP measurements are promising for monitoring the impact of therapeutic interventions for HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.